Report Detail
Global Assisted Reproduction Drug Market Growth (Status and Outlook) 2022-2028
- RnM4391719 |
- 06 March, 2022 |
- Global |
- 87 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
As the global economy mends, the 2021 growth of Assisted Reproduction Drug will have significant change from previous year. According to our (LP Information) latest study, the global Assisted Reproduction Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Assisted Reproduction Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Assisted Reproduction Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Assisted Reproduction Drug market, reaching US$ million by the year 2028. As for the Europe Assisted Reproduction Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Assisted Reproduction Drug players cover Merck Serono, Merck Sharp & Dohme, Livzon Group, and Zhejiang Xianju Pharmaceutical Co., Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Assisted Reproduction Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Gonadotropin Releasing Hormone
Follicle-stimulating Hormone
Human Choroinic Gonadotrophin
Progestogen Hormone
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Down Regultion
Controlled Ovarian Hyperstimulation
Induced Ovulation
luteal Support
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Merck Serono
Merck Sharp & Dohme
Livzon Group
Zhejiang Xianju Pharmaceutical Co., Ltd.
GenSci
Shanghai First Biochemical Pharmaceutical Co. LTD
Ipsen Pharma Biotech
Solvay Pharma
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Assisted Reproduction Drug Market Size 2017-2028
- 2.1.2 Assisted Reproduction Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Assisted Reproduction Drug Segment by Type
- 2.2.1 Gonadotropin Releasing Hormone
- 2.2.2 Follicle-stimulating Hormone
- 2.2.3 Human Choroinic Gonadotrophin
- 2.2.4 Progestogen Hormone
- 2.3 Assisted Reproduction Drug Market Size by Type
- 2.3.1 Assisted Reproduction Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Assisted Reproduction Drug Market Size Market Share by Type (2017-2022)
- 2.4 Assisted Reproduction Drug Segment by Application
- 2.4.1 Down Regultion
- 2.4.2 Controlled Ovarian Hyperstimulation
- 2.4.3 Induced Ovulation
- 2.4.4 luteal Support
- 2.5 Assisted Reproduction Drug Market Size by Application
- 2.5.1 Assisted Reproduction Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Assisted Reproduction Drug Market Size Market Share by Application (2017-2022)
3 Assisted Reproduction Drug Market Size by Player
- 3.1 Assisted Reproduction Drug Market Size Market Share by Players
- 3.1.1 Global Assisted Reproduction Drug Revenue by Players (2020-2022)
- 3.1.2 Global Assisted Reproduction Drug Revenue Market Share by Players (2020-2022)
- 3.2 Global Assisted Reproduction Drug Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Assisted Reproduction Drug by Regions
- 4.1 Assisted Reproduction Drug Market Size by Regions (2017-2022)
- 4.2 Americas Assisted Reproduction Drug Market Size Growth (2017-2022)
- 4.3 APAC Assisted Reproduction Drug Market Size Growth (2017-2022)
- 4.4 Europe Assisted Reproduction Drug Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Assisted Reproduction Drug Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Assisted Reproduction Drug Market Size by Country (2017-2022)
- 5.2 Americas Assisted Reproduction Drug Market Size by Type (2017-2022)
- 5.3 Americas Assisted Reproduction Drug Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Assisted Reproduction Drug Market Size by Region (2017-2022)
- 6.2 APAC Assisted Reproduction Drug Market Size by Type (2017-2022)
- 6.3 APAC Assisted Reproduction Drug Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Assisted Reproduction Drug by Country (2017-2022)
- 7.2 Europe Assisted Reproduction Drug Market Size by Type (2017-2022)
- 7.3 Europe Assisted Reproduction Drug Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Assisted Reproduction Drug by Region (2017-2022)
- 8.2 Middle East & Africa Assisted Reproduction Drug Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Assisted Reproduction Drug Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Assisted Reproduction Drug Market Forecast
- 10.1 Global Assisted Reproduction Drug Forecast by Regions (2023-2028)
- 10.1.1 Global Assisted Reproduction Drug Forecast by Regions (2023-2028)
- 10.1.2 Americas Assisted Reproduction Drug Forecast
- 10.1.3 APAC Assisted Reproduction Drug Forecast
- 10.1.4 Europe Assisted Reproduction Drug Forecast
- 10.1.5 Middle East & Africa Assisted Reproduction Drug Forecast
- 10.2 Americas Assisted Reproduction Drug Forecast by Country (2023-2028)
- 10.2.1 United States Assisted Reproduction Drug Market Forecast
- 10.2.2 Canada Assisted Reproduction Drug Market Forecast
- 10.2.3 Mexico Assisted Reproduction Drug Market Forecast
- 10.2.4 Brazil Assisted Reproduction Drug Market Forecast
- 10.3 APAC Assisted Reproduction Drug Forecast by Region (2023-2028)
- 10.3.1 China Assisted Reproduction Drug Market Forecast
- 10.3.2 Japan Assisted Reproduction Drug Market Forecast
- 10.3.3 Korea Assisted Reproduction Drug Market Forecast
- 10.3.4 Southeast Asia Assisted Reproduction Drug Market Forecast
- 10.3.5 India Assisted Reproduction Drug Market Forecast
- 10.3.6 Australia Assisted Reproduction Drug Market Forecast
- 10.4 Europe Assisted Reproduction Drug Forecast by Country (2023-2028)
- 10.4.1 Germany Assisted Reproduction Drug Market Forecast
- 10.4.2 France Assisted Reproduction Drug Market Forecast
- 10.4.3 UK Assisted Reproduction Drug Market Forecast
- 10.4.4 Italy Assisted Reproduction Drug Market Forecast
- 10.4.5 Russia Assisted Reproduction Drug Market Forecast
- 10.5 Middle East & Africa Assisted Reproduction Drug Forecast by Region (2023-2028)
- 10.5.1 Egypt Assisted Reproduction Drug Market Forecast
- 10.5.2 South Africa Assisted Reproduction Drug Market Forecast
- 10.5.3 Israel Assisted Reproduction Drug Market Forecast
- 10.5.4 Turkey Assisted Reproduction Drug Market Forecast
- 10.5.5 GCC Countries Assisted Reproduction Drug Market Forecast
- 10.6 Global Assisted Reproduction Drug Forecast by Type (2023-2028)
- 10.7 Global Assisted Reproduction Drug Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Merck Serono
- 11.1.1 Merck Serono Company Information
- 11.1.2 Merck Serono Assisted Reproduction Drug Product Offered
- 11.1.3 Merck Serono Assisted Reproduction Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Merck Serono Main Business Overview
- 11.1.5 Merck Serono Latest Developments
- 11.2 Merck Sharp & Dohme
- 11.2.1 Merck Sharp & Dohme Company Information
- 11.2.2 Merck Sharp & Dohme Assisted Reproduction Drug Product Offered
- 11.2.3 Merck Sharp & Dohme Assisted Reproduction Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Merck Sharp & Dohme Main Business Overview
- 11.2.5 Merck Sharp & Dohme Latest Developments
- 11.3 Livzon Group
- 11.3.1 Livzon Group Company Information
- 11.3.2 Livzon Group Assisted Reproduction Drug Product Offered
- 11.3.3 Livzon Group Assisted Reproduction Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Livzon Group Main Business Overview
- 11.3.5 Livzon Group Latest Developments
- 11.4 Zhejiang Xianju Pharmaceutical Co., Ltd.
- 11.4.1 Zhejiang Xianju Pharmaceutical Co., Ltd. Company Information
- 11.4.2 Zhejiang Xianju Pharmaceutical Co., Ltd. Assisted Reproduction Drug Product Offered
- 11.4.3 Zhejiang Xianju Pharmaceutical Co., Ltd. Assisted Reproduction Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Zhejiang Xianju Pharmaceutical Co., Ltd. Main Business Overview
- 11.4.5 Zhejiang Xianju Pharmaceutical Co., Ltd. Latest Developments
- 11.5 GenSci
- 11.5.1 GenSci Company Information
- 11.5.2 GenSci Assisted Reproduction Drug Product Offered
- 11.5.3 GenSci Assisted Reproduction Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 GenSci Main Business Overview
- 11.5.5 GenSci Latest Developments
- 11.6 Shanghai First Biochemical Pharmaceutical Co. LTD
- 11.6.1 Shanghai First Biochemical Pharmaceutical Co. LTD Company Information
- 11.6.2 Shanghai First Biochemical Pharmaceutical Co. LTD Assisted Reproduction Drug Product Offered
- 11.6.3 Shanghai First Biochemical Pharmaceutical Co. LTD Assisted Reproduction Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Shanghai First Biochemical Pharmaceutical Co. LTD Main Business Overview
- 11.6.5 Shanghai First Biochemical Pharmaceutical Co. LTD Latest Developments
- 11.7 Ipsen Pharma Biotech
- 11.7.1 Ipsen Pharma Biotech Company Information
- 11.7.2 Ipsen Pharma Biotech Assisted Reproduction Drug Product Offered
- 11.7.3 Ipsen Pharma Biotech Assisted Reproduction Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Ipsen Pharma Biotech Main Business Overview
- 11.7.5 Ipsen Pharma Biotech Latest Developments
- 11.8 Solvay Pharma
- 11.8.1 Solvay Pharma Company Information
- 11.8.2 Solvay Pharma Assisted Reproduction Drug Product Offered
- 11.8.3 Solvay Pharma Assisted Reproduction Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Solvay Pharma Main Business Overview
- 11.8.5 Solvay Pharma Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Assisted Reproduction Drug. Industry analysis & Market Report on Assisted Reproduction Drug is a syndicated market report, published as Global Assisted Reproduction Drug Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Assisted Reproduction Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
